Due to the coronavirus, many events are canceled. For more information, we invite you to visit the event web site. X

Innovation & Biomarkers in Cancer Drug Developpement - IBCD 2018

29 November 2018 - 30 November 2018


Radisson BLU Royal Hôtel - Rue Fossé-aux-Loups 47, du  1000 Bruxelles


Event date & Times

IBCD 2018 will explore routes through the evolving scientific, methodological and regulatory environment. The combined efforts of the EORTC, NCI, EMA, and AACR with the involvement of FDA and PMDA and Health Technology Assessment specialists will result in a unique program. The 2018-edition will build upon the recommendations and action points decided upon at the IBCD2016-edition. Topics, which will be developed, will include items like Health Technology Assessment (HTA) of biomarker assays, comparative effectiveness research and the translation of findings of clinical trials into daily practice.

La source :